Clinical Trial Update: Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 ascending-dose study of DC371739 in healthy subjects has completed, evaluating safety, tolerability, and pharmacokinetics in the context of hyperlipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• DC371739

Snippet

Sponsor: Guangzhou JOYO Pharma Co., Ltd | Conditions: Hyperlipidemia | Phase 1 | Status: COMPLETED